Income Statement Roivant Sciences Ltd.

Equities

ROIV

BMG762791017

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 16:00:00 2025-06-13 EDT			5-day change	1st Jan Change
11.32 ^USD	-1.31%		+0.80%	-4.31%

06-06	Roivant Sciences Insider Sold Shares Worth $8,454,808, According to a Recent SEC Filing	MT
06-05	Roivant Sciences Ltd. Presents at Jefferies Global Healthcare Conference 2025, Jun-05-2025 04:20 PM

7467d06ef12491fcac7ff63ddf7.epNKaERLEyqa06BMZZbDDHV6OGEi2jA_j9VcXHBZshw.M_ssOnIkdX2v4cE0NaOweAIOCiNyon0S6oQEHkUA8Sgz1Q5bcRQqR-iYmA

Published financial data: ROIVANT SCIENCES LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	23.8M	55.29M	61.28M	125M	29.05M
Total Revenues	23.8M	55.29M	61.28M	125M	29.05M
Cost of Goods Sold, Total	835M	469M	538M	517M	546M
Gross Profit	-811M	-414M	-477M	-393M	-516M
Selling General & Admin Expenses, Total	260M	425M	601M	687M	570M
R&D Expenses	-	-	-	-	-
Other Operating Expenses, Total	260M	425M	601M	687M	570M
Operating Income	-1.07B	-839M	-1.08B	-1.08B	-1.09B
Interest Expense, Total	-2.81M	-7.04M	-27.97M	-34.78M	-
Interest And Investment Income	1.42M	369K	32.18M	146M	258M
Net Interest Expenses	-1.39M	-6.67M	4.22M	112M	258M
Income (Loss) On Equity Invest.	-3.75M	-	-	-	-
Other Non Operating Income (Expenses)	-33.4M	73.06M	-62.19M	-85.03M	5.04M
EBT, Excl. Unusual Items	-1.11B	-772M	-1.14B	-1.05B	-823M
Gain (Loss) On Sale Of Investments	124M	356M	-20.82M	-47.97M	55.19M
Gain (Loss) On Sale Of Assets	86.56M	5.04M	29.28M	5.38B	113M
In Process R&D Expenses	-	-140M	-97.75M	-26.45M	-
Other Unusual Items	-	-373M	-	-	-27M
EBT, Incl. Unusual Items	-899M	-924M	-1.22B	4.25B	-682M
Income Tax Expense	1.69M	369K	5.19M	22.22M	48.17M
Earnings From Continuing Operations	-900M	-924M	-1.23B	4.23B	-730M
Earnings Of Discontinued Operations	-	-	115M	-	373M
Net Income to Company	-900M	-924M	-1.12B	4.23B	-357M
Minority Interest	91M	78.85M	106M	118M	185M
Net Income - (IS)	-809M	-845M	-1.01B	4.35B	-172M
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-809M	-845M	-1.01B	4.35B	-172M
Net Income to Common Excl. Extra Items	-809M	-845M	-1.12B	4.35B	-545M
Per Share Items
Net EPS - Basic	-3.76	-1.26	-1.42	5.55	-0.24
Basic EPS - Continuing Operations	-3.76	-1.26	-1.58	5.55	-0.75
Basic Weighted Average Shares Outstanding	215M	670M	713M	783M	725M
Net EPS - Diluted	-3.76	-1.26	-1.42	5.23	-0.24
Diluted EPS - Continuing Operations	-3.76	-1.26	-1.58	5.23	-0.75
Diluted Weighted Average Shares Outstanding	215M	670M	713M	831M	725M
Normalized Basic EPS	-2.8	-0.6	-0.85	-0.69	-0.45
Normalized Diluted EPS	-2.8	-0.6	-0.85	-0.65	-0.45
Supplemental Items
EBITDA	-	-	-1.06B	-1.06B	-1.07B
EBITA	-1.07B	-839M	-1.07B	-1.07B	-1.09B
EBIT	-1.07B	-839M	-1.08B	-1.08B	-1.09B
EBITDAR	-	-	-1.04B	-1.04B	-1.06B
Total Revenues (As Reported)	-	-	61.28M	125M	-
Effective Tax Rate - (Ratio)	-0.19	-0.04	-0.42	0.52	-7.07
Total Current Taxes	1.69M	369K	5.19M	22.22M	48.17M
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	-602M	-404M	-603M	-541M	-330M
Interest on Long-Term Debt	-	-	102K	34.78M	30.56M
Supplemental Operating Expense Items
General and Administrative Expenses	260M	425M	-	-	570M
Research And Development Expense From Footnotes	833M	623M	623M	528M	550M
Net Rental Expense, Total	12.87M	15.2M	15.82M	13.1M	13.49M
Imputed Operating Lease Interest Expense	1.36M	3.24M	9.18M	7.43M	-
Imputed Operating Lease Depreciation	11.51M	11.96M	6.64M	5.67M	-
Stock-Based Comp., COGS (Total)	22.64M	40.84M	30.91M	34.6M	39.78M
Stock-Based Comp., R&D Exp. (Total)	-	22.9M	-	-	-
Stock-Based Comp., G&A Exp. (Total)	62.32M	501M	-	-	240M
Stock-Based Comp., SG&A Exp. (Total)	-	-	187M	165M	-
Stock-Based Comp., Other (Total)	-	-	264K	191K	9.74M
Total Stock-Based Compensation	84.96M	565M	218M	200M	289M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	2.06B	2.06B	1.68B	6.54B	2.72B
Short Term Investments	-	-	-	-	2.17B
Total Cash And Short Term Investments	2.06B	2.06B	1.68B	6.54B	4.89B
Accounts Receivable, Total	11.22M	-	30.38M	53.54M	-
Other Receivables	2.61M	-	2.36M	29.27M	-
Notes Receivable	-	-	-	-	-
Total Receivables	13.83M	-	32.74M	82.81M	-
Inventory	-	-	2.76M	35.25M	-
Prepaid Expenses	39.54M	-	60.83M	55.1M	-
Restricted Cash	77.7M	3.9M	5.01M	5.37M	2.36M
Other Current Assets, Total	874K	82.22M	20.44M	17.6M	111M
Total Current Assets	2.19B	2.15B	1.8B	6.73B	5B
Net Property Plant And Equipment	77.03M	86.95M	92.34M	65.95M	101M
Long-term Investments	290M	326M	304M	248M	303M
Other Intangibles, Total	-	-	145M	138M	-
Deferred Charges Long-Term	2.3M	-	-	-	-
Other Long-Term Assets, Total	33.83M	25.82M	49.48M	39.11M	32.86M
Total Assets	2.59B	2.59B	2.39B	7.22B	5.44B
Liabilities
Accounts Payable, Total	20.55M	34.58M	37.83M	53.22M	23.69M
Accrued Expenses, Total	76.94M	128M	167M	176M	114M
Current Portion of Long-Term Debt	-	-	40.72M	12M	-
Current Portion of Leases	12.31M	11.4M	13.78M	9.89M	9.84M
Current Income Taxes Payable	207K	-	542K	10.47M	416K
Unearned Revenue Current, Total	5.92M	10.15M	12.44M	4.17M	1.17M
Other Current Liabilities	103M	708K	-	1.42M	-
Total Current Liabilities	219M	184M	272M	267M	149M
Long-Term Debt	170M	210M	376M	431M	-
Long-Term Leases	62.38M	62.47M	57.05M	47.26M	90.33M
Unearned Revenue Non Current	-	13.74M	-	-	-
Other Non Current Liabilities	76.06M	53.1M	77M	29.34M	10M
Total Liabilities	528M	524M	782M	774M	250M
Additional Paid In Capital	3.81B	4.42B	4.93B	5.4B	4.56B
Retained Earnings	-1.92B	-2.76B	-3.77B	576M	116M
Comprehensive Income and Other	-98.56M	-946K	-2.62M	-4.08M	9.44M
Total Common Equity	1.8B	1.66B	1.16B	5.97B	4.69B
Minority Interest	264M	404M	450M	480M	500M
Total Equity	2.06B	2.06B	1.61B	6.45B	5.19B
Total Liabilities And Equity	2.59B	2.59B	2.39B	7.22B	5.44B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	223M	701M	767M	739M	680M
ECS Total Common Shares Outstanding	223M	695M	760M	807M	696M
Book Value / Share	8.07	2.38	1.52	7.4	6.74
Tangible Book Value	1.8B	1.66B	1.01B	5.83B	4.69B
Tangible Book Value Per Share	8.07	2.38	1.33	7.23	6.74
Total Debt	245M	284M	487M	500M	100M
Net Debt	-1.81B	-1.78B	-1.19B	-6.04B	-4.79B
Debt Equivalent Oper. Leases	103M	122M	127M	105M	108M
Minority Interest, Total (Incl. Fin. Div)	264M	404M	450M	480M	500M
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	3	3	5	5	3
Full Time Employees	620	863	904	908	750

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	-809M	-845M	-1.01B	4.35B	-172M
Depreciation & Amortization - CF	-	-	11.39M	12.4M	14.07M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	7.47M	9.63M	-
Depreciation & Amortization, Total	-	-	18.86M	22.04M	14.07M
(Gain) Loss From Sale Of Asset	-115M	-5.04M	-29.28M	-5.38B	-490M
(Gain) Loss on Sale of Investments - (CF)	-95.53M	-356M	20.82M	47.97M	-125M
Asset Writedown & Restructuring Costs	352M	78.22M	87.75M	-	-
(Income) Loss On Equity Investments - (CF)	3.75M	-	-	-	-
Stock-Based Compensation (CF)	84.96M	565M	218M	200M	289M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	-79.72M	-141M	-157M	-21.68M	-278M
Change In Accounts Payable	3.75M	15.4M	4.36M	22.68M	-18.17M
Change in Unearned Revenues	-	17.97M	-	-	-
Change in Other Net Operating Assets	104M	-6.27M	1.99M	-3.65M	-58.88M
Cash from Operations	-552M	-678M	-843M	-765M	-839M
Capital Expenditure	-5.81M	-17.44M	-12.69M	-1.38M	-4.6M
Cash Acquisitions	21.44M	-	-	-	-
Divestitures	-19.08M	-	-6.71M	5.2B	340M
Sale (Purchase) of Intangible assets	-	-	-140M	-	-
Investment in Marketable and Equity Securities, Total	-28.25M	320M	-	-	-2.1B
Other Investing Activities, Total	-	561K	115M	8.59M	79K
Cash from Investing	-31.7M	303M	-44.27M	5.2B	-1.77B
Long-Term Debt Issued, Total	-	36.4M	160M	-	-
Total Debt Issued	-	36.4M	160M	-	-
Long-Term Debt Repaid, Total	-	-21.59M	-30.14M	-30.7M	-52.75M
Total Debt Repaid	-	-21.59M	-30.14M	-30.7M	-52.75M
Issuance of Common Stock	-	313M	315M	255M	50.62M
Repurchase of Common Stock	-113K	-	-10.88M	-37.72M	-1.33B
Other Financing Activities, Total	456M	-21.44M	65.48M	233M	113M
Cash from Financing	456M	307M	499M	419M	-1.22B
Foreign Exchange Rate Adjustments	-	-	6.28M	616K	747K
Net Change in Cash	-128M	-67.64M	-382M	4.86B	-3.82B
Supplemental Items
Cash Interest Paid	2.02M	5.54M	5.3M	10.27M	5.96M
Cash Income Tax Paid (Refund)	4.08M	916K	5.13M	12.35M	61.91M
Levered Free Cash Flow	-565M	30.99M	-598M	-526M	-375M
Unlevered Free Cash Flow	-564M	35.39M	-580M	-504M	-375M
Change In Net Working Capital	-26.46M	-12.15M	-9.32M	49.52M	-5.48M
Net Debt Issued / Repaid	-	14.81M	130M	-30.7M	-52.75M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	-26.42	-20.26	-27.08	-14.04	-10.73
Return on Total Capital	-29.12	-22.54	-30.34	-14.94	-11.52
Return On Equity %	-43.17	-44.82	-67.05	105.04	-12.54
Return on Common Equity	-42.26	-48.93	-79.84	122.05	-10.23
Margin Analysis
Gross Profit Margin %	-3.41K	-748.5	-778.5	-314.52	-1.78K
SG&A Margin	1.09K	768.79	979.94	550.86	1.96K
EBITDA Margin %	-	-	-1.73K	-847.72	-3.69K
EBITA Margin %	-4.5K	-1.52K	-1.75K	-857.66	-3.74K
EBIT Margin %	-4.5K	-1.52K	-1.76K	-865.37	-3.74K
Income From Continuing Operations Margin %	-3.78K	-1.67K	-2.01K	3.39K	-2.51K
Net Income Margin %	-3.4K	-1.53K	-1.65K	3.48K	-591.96
Net Avail. For Common Margin %	-3.4K	-1.53K	-1.83K	3.48K	-1.88K
Normalized Net Income Margin	-2.53K	-730.62	-984.47	-433.2	-1.14K
Levered Free Cash Flow Margin	-2.38K	56.05	-975.56	-421.44	-1.29K
Unlevered Free Cash Flow Margin	-2.37K	64.01	-947.04	-404.02	-1.29K
Asset Turnover
Asset Turnover	0.01	0.02	0.02	0.03	0
Fixed Assets Turnover	0.32	0.67	0.68	1.58	0.36
Receivables Turnover (Average Receivables)	3.2	-	3.58	2.97	-
Inventory Turnover (Average Inventory)	-	-	-	27.22	-
Short Term Liquidity
Current Ratio	9.99	11.64	6.6	25.24	33.47
Quick Ratio	9.45	11.18	6.27	24.81	32.71
Operating Cash Flow to Current Liabilities	-2.52	-3.68	-3.1	-2.87	-5.62
Days Sales Outstanding (Average Receivables)	114.21	-	102.02	123.07	-
Days Outstanding Inventory (Average Inventory)	-	-	-	13.45	-
Average Days Payable Outstanding	6.75	21.45	-	30.31	12.62
Cash Conversion Cycle (Average Days)	-	-	-	106.21	-
Long Term Solvency
Total Debt/Equity	11.88	13.77	30.3	7.75	1.93
Total Debt / Total Capital	10.62	12.1	23.25	7.19	1.89
LT Debt/Equity	11.28	13.22	26.91	7.41	1.74
Long-Term Debt / Total Capital	10.09	11.62	20.65	6.88	1.71
Total Liabilities / Total Assets	20.38	20.26	32.73	10.72	4.59
EBIT / Interest Expense	-381.24	-119.14	-38.53	-31.05	-
EBITDA / Interest Expense	-376.66	-116.98	-37.29	-30.04	-
(EBITDA - Capex) / Interest Expense	-378.72	-119.45	-37.74	-30.08	-
Total Debt / EBITDA	-0.23	-0.34	-0.47	-0.48	-0.09
Net Debt / EBITDA	1.71	2.16	1.14	5.78	4.52
Total Debt / (EBITDA - Capex)	-0.23	-0.34	-0.46	-0.48	-0.09
Net Debt / (EBITDA - Capex)	1.7	2.11	1.13	5.77	4.5
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-64.85	132.34	10.84	103.65	-11.19
Gross Profit, 1 Yr. Growth %	312.4	92.57	15.28	-17.73	29.48
EBITDA, 1 Yr. Growth %	-	-	27.11	-0.08	41.62
EBITA, 1 Yr. Growth %	101.14	76.69	27.57	0.02	39.42
EBIT, 1 Yr. Growth %	101.14	76.69	28.46	0.22	39.42
Earnings From Cont. Operations, 1 Yr. Growth %	58.46	2.65	33.1	-443.99	-116.05
Net Income, 1 Yr. Growth %	-167.41	4.45	19.37	-531	-103.95
Normalized Net Income, 1 Yr. Growth %	322.71	75.76	49.35	-10.39	4.48
Diluted EPS Before Extra, 1 Yr. Growth %	80.73	-1.74	25.19	-431.01	-113.39
Accounts Receivable, 1 Yr. Growth %	205.86	-	683.37	76.26	-
Inventory, 1 Yr. Growth %	-	-	-	1.18K	-
Net Property, Plant and Equip., 1 Yr. Growth %	4.19	12.88	6.2	-28.58	70.38
Total Assets, 1 Yr. Growth %	4.55	-0.18	-7.56	202.25	-24.72
Tangible Book Value, 1 Yr. Growth %	-11.53	-7.83	-38.87	475.66	-21.46
Common Equity, 1 Yr. Growth %	-11.53	-7.83	-30.13	415.53	-21.46
Cash From Operations, 1 Yr. Growth %	-27.23	22.75	24.44	-9.26	9.69
Capital Expenditures, 1 Yr. Growth %	18.1	200.31	-27.22	-89.11	232.78
Levered Free Cash Flow, 1 Yr. Growth %	2.15K	-116.07	-1.72K	-11.72	9
Unlevered Free Cash Flow, 1 Yr. Growth %	2.67K	-118.52	-1.5K	-12.81	9
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	219.98	-9.62	60.48	50.24	-4.01
Gross Profit, 2 Yr. CAGR %	2.07K	45.06	49	-2.61	10.16
EBITDA, 2 Yr. CAGR %	-	-	-	12.7	16.51
EBITA, 2 Yr. CAGR %	19.61	25.52	50.13	12.96	15.9
EBIT, 2 Yr. CAGR %	19.61	25.52	50.65	13.46	15.9
Earnings From Cont. Operations, 2 Yr. CAGR %	5.44	27.54	16.89	113.98	-9.4
Net Income, 2 Yr. CAGR %	-11.87	-16.09	11.66	126.83	-58.72
Normalized Net Income, 2 Yr. CAGR %	48.04	68.36	62.02	15.69	-8.15
Diluted EPS Before Extra, 2 Yr. CAGR %	13.15	-22.11	10.91	103.57	-17.35
Accounts Receivable, 2 Yr. CAGR %	162.39	-	-	271.58	-
Net Property, Plant and Equip., 2 Yr. CAGR %	163.3	8.45	9.49	-12.91	4.63
Total Assets, 2 Yr. CAGR %	36.6	2.16	-3.94	67.15	50.84
Tangible Book Value, 2 Yr. CAGR %	58.35	-9.7	-24.94	87.59	115.13
Common Equity, 2 Yr. CAGR %	58.35	-9.7	-19.75	89.79	101.22
Cash From Operations, 2 Yr. CAGR %	-26.55	-5.49	23.59	6.26	-0.23
Capital Expenditures, 2 Yr. CAGR %	-28.62	88.33	47.84	-71.85	-39.8
Levered Free Cash Flow, 2 Yr. CAGR %	-	10.99	76.05	277.43	-4.39
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	31.86	74.26	249.31	-4.39
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	187.6	-3.26	73.74	-19.3
Gross Profit, 3 Yr. CAGR %	-	522.2	34.37	22.24	7.67
EBITDA, 3 Yr. CAGR %	-	-	-	-	8.8
EBITA, 3 Yr. CAGR %	-	3.87	26.2	31.12	9.01
EBIT, 3 Yr. CAGR %	-	3.87	26.49	31.51	9.01
Earnings From Cont. Operations, 3 Yr. CAGR %	-	4.5	29.37	67.51	-7.57
Net Income, 3 Yr. CAGR %	-	-6.74	-5.63	75.16	-41.18
Normalized Net Income, 3 Yr. CAGR %	-	13.69	61.77	32.99	-6.54
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-24.54	-8.76	59.69	-15.88
Accounts Receivable, 3 Yr. CAGR %	-	-	102.31	-	-
Net Property, Plant and Equip., 3 Yr. CAGR %	-	98.54	7.69	-5.04	5.15
Total Assets, 3 Yr. CAGR %	-	23.04	-1.19	40.76	28.12
Tangible Book Value, 3 Yr. CAGR %	-	32.21	-20.71	48.02	41.43
Common Equity, 3 Yr. CAGR %	-	32.21	-17.1	49.18	41.43
Cash From Operations, 3 Yr. CAGR %	-	-12.84	3.59	11.5	7.39
Capital Expenditures, 3 Yr. CAGR %	-	15.23	37.18	-38.03	-35.87
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	187.51	39.71	116.6
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	205.51	38.18	108.62
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	121.82	-15.56
Gross Profit, 5 Yr. CAGR %	-	-	-	196.32	21.3
EBITA, 5 Yr. CAGR %	-	-	-	7.42	15.34
EBIT, 5 Yr. CAGR %	-	-	-	7.61	15.34
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	39.19	5.14
Net Income, 5 Yr. CAGR %	-	-	-	33.08	-32.2
Normalized Net Income, 5 Yr. CAGR %	-	-	-	14.48	18.27
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	12.24	-18.43
Accounts Receivable, 5 Yr. CAGR %	-	-	-	101.05	-
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	42.79	6.45
Total Assets, 5 Yr. CAGR %	-	-	-	39.08	17.03
Tangible Book Value, 5 Yr. CAGR %	-	-	-	52.07	18.19
Common Equity, 5 Yr. CAGR %	-	-	-	52.78	18.19
Cash From Operations, 5 Yr. CAGR %	-	-	-	-5.65	2.04
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-34.42	-1.32
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	71.68
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	79.11